The table below shows CHAMPIONS ONCOLOGY, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$56.94M
$50.16M
$53.87M
$49.11M
$41.04M
$32.12M
Cost of revenue
$28.39M
$29.40M
$29.53M
$23.63M
$21.45M
$17.00M
Gross profit
-
-
-
-
-
-
R&D
$6.83M
$9.54M
$11.54M
$9.37M
$7.20M
$5.85M
SG&A
CSBR annual revenue (10-K history)
CHAMPIONS ONCOLOGY, INC. reported annual revenue of $56.94M for fiscal year 2025. That is up 13.5% from $50.16M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $20.24M (FY 2018) to $56.94M. Figures come from the company's audited annual reports as filed with the SEC.